// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Tuberculous Myositis Presenting as a Relapse of Dermatomyositis

Sherry Rohekar - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Development of Psoriasis in Patients on Biological Response Modifiers

Jacob Karsh - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Psoriasis

Adalimumab

Rheumatological Causes of Subglottic Stenosis A Case Series

Evelyn Kwok - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Therapeutic Options in Fibroblastic Rheumatism: Case Report and Review of the Literature

Iman Hemmati - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Inflammatory RANK-Expressing Neutrophils Resorb Bone in K/BxN Arthritis

Isabelle Allaeys - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Elaszym

Neuropsychiatric Systemic Lupus Erythematosus: Association with Global Disease Activity

Stephanie Carpentier - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Neuropsychiatric systemic lupus erythematosus

N/A

The Role of Biological Agents in the Management of Large Vessel Vasculitis (LVV): A Systematic Review and Meta-Analysis

Christian Pagnoux - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Risk of Venous Thromboembolism in Individuals with Dermatomyositis and Polymyositis

Eric Sayre - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

A Screening Failure

Kamran Shojania - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Erosion Case Definition and Scoring Reliability Exercise using a New Outcome Measurement Tool, High-Resolution Peripheral Quantitative Computed Tomography, in Rheumatoid Arthritis

Dominique Toepfer - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Glucocorticosteroids and Mortality Risk in Rheumatoid Arthritis - Results of a Population Based Study

Antonio Avina-Zubieta - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Prednisone

Giant Cell Arteritis in an HIV Patient: A Case Report and Review of the Literature

Iman Hemmati - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Large vessel vasculitis

N/A

Intra-Articular Corticosteroids Injections in the Lower Extremities: How do Ankles Respond?

Claire MA LeBlanc - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Thromboembolism in Rheumatology: Investigation of the Risks of Deep Vein Thrombosis and Pulmonary Embolism in Inflammatory Arthritis, Connective Tissue Diseases, Vasculitis and Myositis

Janet Pope - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Inflammatory Arthritis

N/A

Efficacy and Safety of Adalimumab in Pediatric Patients with Enthesitis Related Arthritis

Shirley Tse - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Adalimumab

Development of a Biologic Safety Screening Tool: Pre-Implementation Chart Review

McCarthy Anne - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

On the Precipice: A Prospective Exploration of Medical Student- Expectation of the Transition from Pre-Clinical to Clinical Training

Pamela Brett-MacLean - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evaluation of the New ACR/EULAR Criteria for the Classification of Systemic Sclerosis in the Canadian Scleroderma Research Group Cohort

Marie Hudson - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

High Prevalence of Obesity Among Early and Established Rheumatoid Arthritis

Ines Colmegna - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Rheumatoid arthritis

N/A

Economic Evaluation using Observational Data: A Scoping Review

Claire Bombardier - Canadian Rheumatology Association (CRA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Copyright © 2026. QuantiNova All rights reserved